3 Hz Bands That Define Optimal Pulse Frequency Settings in PBM

Updated: August 12, 2026 | 12-minute read

There is no single best pulse rate for red light therapy. Photobiomodulation (PBM) studies have tested continuous wave (CW) delivery and pulsed wave (PW) delivery at frequencies ranging from a few hertz to several kilohertz, but the results do not support assigning one universal biological target to each Hz value.

A pulse frequency is only one part of a light-delivery protocol. Wavelength, pulse width, duty cycle, peak irradiance, time-averaged irradiance, exposure time, treatment distance, beam geometry, and total radiant exposure can all change the result. A device that displays "40 Hz" without disclosing the rest of these parameters does not provide enough information to reproduce a published study or calculate a reliable dose.

The most defensible conclusion is therefore straightforward: pulsing can matter under specific experimental conditions, but pulsed delivery is not universally superior to continuous wave, and no frequency can be recommended independently of the complete protocol.

What research actually says about pulse frequency

Pulse frequencies investigated in photobiomodulation

Common belief: each frequency has a fixed purpose—for example, 10 Hz for mitochondria, 40 Hz for the brain, or 100 Hz for muscles and joints.

What the evidence supports: frequency-dependent responses have been reported in some cell, animal, and early human studies, but the findings are heterogeneous and protocol-specific.

A 2010 review by Hashmi et al. examined studies using pulse frequencies from approximately 2 Hz to 8,000 Hz. Some experiments favored pulsed delivery, some found similar outcomes, and others favored continuous wave. The review did not identify one pulse frequency that consistently performed best across applications.

Several frequently cited frequencies illustrate why context matters:

• 10 Hz: has been studied in specific animal wound-healing and brain-injury models and in some transcranial or intranasal PBM protocols. These findings do not establish 10 Hz as a universal setting for mitochondrial activity, the autonomic nervous system, skin care, or recovery.
• 40 Hz: has attracted attention in transcranial research because it overlaps the gamma-frequency range of brain activity. Early studies have reported changes in EEG or cognitive measures under particular wavelengths, irradiances, duty cycles, and treatment schedules. This evidence should not be generalized to ordinary body panels or presented as an established treatment for neurological disease.
• 100 Hz and higher: have been tested in wound, neural, bone, pain, and cell studies, but the outcomes are inconsistent. A frequency appearing in a successful experiment does not make it the preferred frequency for all musculoskeletal or connective-tissue applications.
• Other frequencies: results at 300 Hz and at frequencies in the kilohertz range further demonstrate that the research cannot be reduced to a three-band 10/40/100 Hz chart.

Pulse frequency should therefore be described as an experimental and device parameter—not as a stand-alone clinical prescription.

How pulse frequency, duty cycle, and irradiance determine dose

Process diagram showing the correct relationship between pulse parameters and radiant exposure

Frequency and duty cycle are not interchangeable.

• Pulse frequency (Hz) is the number of pulses delivered per second.
• Pulse width is the duration of each on-phase.
• Duty cycle is the percentage of time the light is on.
• Peak irradiance is the irradiance during the on-phase.
• Time-averaged irradiance averages the on- and off-phases over time.

For a rectangular pulse train, duty cycle can be calculated from frequency and pulse width when both are known:

Duty cycle = pulse frequency × pulse width

The correct radiant-exposure calculation depends on how irradiance was reported:

If the stated irradiance is the on-phase peak:

Radiant exposure (J/cm²) = peak irradiance (mW/cm²) × duty cycle × time (seconds) ÷ 1000

If the stated irradiance is already time-averaged:

Radiant exposure (J/cm²) = average irradiance (mW/cm²) × time (seconds) ÷ 1000

Do not multiply by duty cycle again when the manufacturer or test report already provides time-averaged irradiance.

For example, a pulsed source with a peak irradiance of 100 mW/cm², a 50% duty cycle, and a 600-second exposure delivers an estimated surface radiant exposure of:

100 × 0.50 × 600 ÷ 1000 = 30 J/cm²

The same source operating continuously for 600 seconds would deliver 60 J/cm², assuming the CW irradiance is also 100 mW/cm². This comparison is valid only when the values refer to the same measurement plane and the same type of irradiance.

Before calculating dose, confirm:

1. The treatment distance and measurement plane.
2. Whether the value is peak, center-point, spatial-average, or time-average irradiance.
3. The pulse width, duty cycle, frequency, and waveform shape.
4. Which wavelength channels are pulsed.
5. The measurement instrument, spectral response, warm-up time, and spatial grid.
6. Whether optical output remains stable during the session.

Equal J/cm² values should not automatically be treated as biologically equivalent. PBM does not always obey a simple reciprocity rule in which lower irradiance can be exchanged for proportionally longer exposure time without changing the outcome.

One product example illustrates the distinction between an adjustable feature and a validated protocol. REDDOT lists the RDPRO 1500-ULTRA with a 0–40 Hz adjustable pulse range, irradiance above 200 mW/cm² at 6 inches, and six preset wellness modes. These specifications describe available controls, but they do not by themselves establish which frequency is optimal for a particular biological target. Reproducible use still requires disclosure of pulse width, duty cycle, peak and time-averaged irradiance, pulsed wavelength channels, and the exact settings used by each preset mode.

Matching a published protocol to an application and device

Comparison of Physical Dimensions of Red Light Therapy Devices

Target depth alone does not determine the correct pulse frequency. Light propagation depends primarily on wavelength, tissue optical properties, beam geometry, treatment distance, and incident irradiance. Pulse structure may change the temporal delivery of energy, but frequency alone does not make light penetrate several centimeters deeper or remove the need for an adequate average irradiance.

Use the following framework instead of a tissue-to-Hz chart:

For skin applications, many published studies have used continuous delivery successfully; there is no accepted 10–20 Hz standard for collagen support. For musculoskeletal applications, studies use varied CW and PW protocols, so 20–40 Hz should not be presented as a universal recovery range. In transcranial research, 10 Hz, 40 Hz, 100 Hz, and continuous delivery have all been investigated, but these protocols require device-specific dosimetry and should not be copied to unrelated devices.

The safest evidence-based approach is to match the complete parameters of a relevant, validated protocol rather than selecting a frequency because its number appears in a different study.

What studies comparing continuous and pulsed delivery show

Researcher reviewing continuous-wave and pulsed-wave photobiomodulation data

The evidence does not show that pulsed delivery is categorically better than continuous wave.

The main difficulty is study heterogeneity. Published comparisons often differ in wavelength, light source, peak power, average irradiance, duty cycle, total energy, treatment schedule, tissue model, and outcome. If these parameters are not controlled, an apparent "frequency effect" may partly reflect a dose or device difference.

For users without a validated pulsed protocol, continuous wave is generally easier to quantify because it avoids uncertainty about duty cycle and peak-to-average conversion. That does not make CW universally superior; it simply makes the surface dose easier to calculate.

Users should follow the device instructions and any indication-specific guidance from a qualified professional. Moving from CW to 10 Hz or 40 Hz should not be described as a casual neurological experiment, especially when the device has no validated protocol for that intended use.

How to verify whether a device delivers its stated pulse settings

Cutaway diagram of a light therapy device showing the components and tests relevant to pulse accuracy

A frequency setting is meaningful only when the optical output has been measured. Electrical or quality-system certifications cannot substitute for waveform testing.

A suitable verification setup uses a fast optical detector and oscilloscope at the stated treatment plane. The report should document:

• Measured pulse frequency and tolerance.
• Pulse width and duty cycle.
• Waveform shape, rise time, and fall time.
• Peak and time-averaged optical output.
• Off-state optical leakage.
• Which wavelength channels are pulsed.
• Stability after warm-up and across the full session.
• Center, edge, minimum, maximum, and spatial-average irradiance.

Thermal management and production controls remain important because LED output and driver behavior can drift as components heat. However, inspections for grounding, wiring, leakage current, or assembly quality do not directly prove optical pulse accuracy. Each performance claim needs a test method designed to measure that parameter.

Certification scope must also be described accurately:

• ETL or another safety listing applies to the models and standards named in the listing. It does not automatically validate biological efficacy or every optical-output claim.
• ISO 13485 certification concerns the manufacturer's quality management system within the certificate scope; it is not a product efficacy certification.
• MDSAP is a regulatory audit program for a manufacturer's quality management system; it does not establish a preferred pulse frequency.
• FDA establishment registration and device listing do not mean that the FDA has approved, cleared, certified, or verified the effectiveness of the establishment or device.（Some red light therapy panels are FDA-exempt.）
• CE marking indicates conformity with applicable EU requirements under the relevant conformity-assessment route. The exact product, intended use, directives or regulations, standards, and supporting reports must be identified.

The strongest evidence that a stated frequency is real is a model-specific optical waveform report—not a general company certificate.

EMC and photobiological safety of pulsed light

Safety laboratory evaluating optical and electromagnetic characteristics of a pulsed light therapy device

Pulse frequency is not a complete safety metric. Optical safety depends on wavelength, spectral irradiance or radiance, peak and average output, pulse duration, exposure time, treatment distance, viewing geometry, and the tissue exposed. Thermal behavior and user instructions also matter.

IEC 62471 and applicable product-specific standards provide frameworks for evaluating photobiological hazards from lamps and lamp systems. For a pulsed source, the applicable assessment must use the actual waveform and exposure conditions. A generic statement that a device complies with IEC 62471 is less useful than a report that identifies the exact model, operating mode, test distance, measurement conditions, and risk-group result.

EMC behavior also cannot be predicted from pulse frequency alone. Emissions depend on the driver topology, internal switching frequency, edge speed, harmonics, filtering, grounding, enclosure, and cables. A higher displayed PBM pulse rate does not simply cause current spikes to "accumulate."

An EMC report demonstrates compliance with specified emission and immunity requirements under the tested configuration. It does not prove photobiological safety, pulse accuracy, clinical efficacy, or the absence of all electromagnetic energy.

For practical use:

• Follow the manufacturer's distance, time, eye-protection, and operating instructions.
• Do not look directly into high-output LEDs unless the instructions and optical-safety assessment specifically permit it.
• Stop use if there is pain, burning, persistent redness, visual disturbance, or another unexpected reaction.
• People with photosensitivity, relevant eye conditions, photosensitizing medication use, or a history of light-triggered neurological symptoms should obtain appropriate professional guidance before using a pulsed light device.

What to check before trusting a pulse setting

Checklist for evaluating pulse settings on a red light therapy device

Use this checklist when evaluating a pulsed red light therapy device:

1. Wavelength and channels: Which wavelengths are present, and which channels actually pulse?
2. Measured frequency: What is the tolerance between the selected and measured Hz value?
3. Pulse width and duty cycle: Are they fixed or adjustable, and do they change with frequency?
4. Peak irradiance: What is the on-phase output at the actual treatment distance?
5. Time-averaged irradiance: What average optical power reaches the treatment plane?
6. Waveform quality: Are rise time, fall time, overshoot, droop, and off-state output documented?
7. Spatial performance: Are center, edge, minimum, maximum, average, and uniformity reported after warm-up?
8. Measurement method: Was a calibrated, spectrally appropriate instrument used?
9. Safety scope: Do the reports name the exact model, configuration, operating mode, standard, and test distance?
10. Intended use: Does the marketed application stay within the device's substantiated and legally permitted intended use?

Wavelength consistency should be evaluated through measured peak wavelength, spectral distribution, full width at half maximum, channel output, and production tolerance. A small shift such as 660 nm to 665 nm should not be described as automatically invalidating a pulse protocol; its significance must be assessed within the complete spectral and dosimetric context.

Key Takeaways

• There is no universal best pulse rate for red light therapy.
• Research does not support a fixed rule that 10 Hz is for mitochondria, 40 Hz is for the brain, and 100 Hz is for muscles or connective tissue.
• Frequency, pulse width, duty cycle, peak irradiance, average irradiance, wavelength, time, and distance must be reported together.
• When peak irradiance is used, calculate radiant exposure as peak mW/cm² × duty cycle × seconds ÷ 1000.
• When time-averaged irradiance is used, do not multiply by duty cycle a second time.
• Pulsed and continuous delivery have both produced positive and negative results under different conditions; neither is universally superior.
• Certifications and registrations do not replace model-specific waveform and optical-output testing.
• The most defensible setting is the one that matches a relevant validated protocol and the exact device configuration.

FAQ

What pulse rate should I use for red light therapy?

There is no evidence-based universal setting. Use the frequency specified by a relevant validated protocol or by the device instructions for its substantiated intended use. If no pulse width, duty cycle, peak output, average output, or protocol is available, the Hz value alone is not enough to make a scientifically supported choice. Continuous wave is often easier to quantify, but it is not automatically better for every application.

Can red light therapy clear clogged arteries?

There is no established clinical evidence that red light therapy clears arterial blockages or treats atherosclerosis. Cellular or preclinical findings involving circulation and inflammation should not be converted into this claim. Red light therapy must not replace cardiovascular diagnosis or established medical treatment.

What are the signs of excessive exposure?

Unexpected heat, persistent redness, pain, burning, headache, eye discomfort, or visual disturbance are reasons to stop the session and review the device instructions. Red and near-infrared light do not cause UV sunburn, although an inadequately controlled high-output device can produce thermal discomfort or irritation. Persistent symptoms warrant appropriate medical advice.

Is 10 minutes of red light therapy enough?

Time alone cannot answer this question. Ten minutes at a time-averaged irradiance of 10 mW/cm² equals 6 J/cm² at the treatment plane, while ten minutes at 100 mW/cm² equals 60 J/cm². Whether either exposure is appropriate depends on the validated protocol, wavelength, treatment site, distance, schedule, and user. A full-body panel does not automatically require a longer exposure merely because it illuminates a larger area at the same time.

References

• Hashmi JT, Huang YY, Sharma SK, et al. "Effect of Pulsing in Low-Level Light Therapy." Lasers in Surgery and Medicine. 2010;42(6):450–466. https://doi.org/10.1002/lsm.20950
• Salehpour F, Mahmoudi J, Kamari F, et al. "Brain Photobiomodulation Therapy: A Narrative Review." Molecular Neurobiology. 2018;55:6601–6636. https://doi.org/10.1007/s12035-017-0852-4
• Keshri GK, Gupta A, Yadav A, et al. "Photobiomodulation with Pulsed and Continuous Wave Near-Infrared Laser (810 nm, Al-Ga-As) Augments Dermal Wound Healing in Immunosuppressed Rats." PLOS ONE. 2016;11(11):e0166705. https://doi.org/10.1371/journal.pone.0166705
• Kim HB, Baik KY, Choung PH, Chung JH. "Pulse Frequency Dependency of Photobiomodulation on the Bioenergetic Functions of Human Dental Pulp Stem Cells." Scientific Reports. 2017;7:15927. https://doi.org/10.1038/s41598-017-15754-2
• Tang L, Jiang H, Sun M, et al. "Pulsed Transcranial Photobiomodulation Generates Distinct Beneficial Neurocognitive Effects Compared with Continuous Wave Transcranial Light." Lasers in Medical Science. 2023;38:203. https://doi.org/10.1007/s10103-023-03865-4
• Zein R, Selting W, Hamblin MR. "Review of Light Parameters and Photobiomodulation Efficacy: Dive into Complexity." Journal of Biomedical Optics. 2018;23(12):120901. https://doi.org/10.1117/1.JBO.23.12.120901
• Huang YY, Chen AC, Carroll JD, Hamblin MR. "Biphasic Dose Response in Low Level Light Therapy." Dose-Response. 2009;7(4):358–383. https://doi.org/10.2203/dose-response.09-027.Hamblin
• U.S. Food and Drug Administration. "Photobiomodulation (PBM) Devices—Premarket Notification [510(k)] Submissions." Draft Guidance, 2023. https://www.fda.gov/media/164417/download
• U.S. Food and Drug Administration. "Important Reminders about Registration and Listing." https://www.fda.gov/medical-devices/device-registration-and-listing/important-reminders-about-registration-and-listing
• International Electrotechnical Commission. "IEC 62471: Photobiological Safety of Lamps and Lamp Systems."
• International Organization for Standardization. "ISO 13485—Medical Devices—Quality Management Systems." https://www.iso.org/iso-13485-medical-devices.html
• European Union. "CE Marking—Obtaining the Certificate, EU Requirements." https://europa.eu/youreurope/business/product-rules-compliance/general-product-compliance/ce-marking/index_en.htm
• REDDOT LED. "RDPRO 1500-ULTRA: Medical-Grade Power, High Irradiance, Ultra-Thin Phototherapy Panel." https://www.reddotled.com/ultra-slim-light-medical-grade-power-slim-design.html